Efficacy and Safety of Alirocumab in Patients with Hypercholesterolemia not on Statin Therapy: the ODYSSEY CHOICE II Study
Presentation prepared and held by Prof. Erik Stroes (AMC Amsterdam, The Netherlands) in Clinical Breakthroughs session: Modifying LDL cholesterol to prevent CV events, Tuesday, May 26, 2015 during ISA2015 (Amsterdam, The Netherlands).
To view slides, click on images
Stroes_CHOICE_II_25_may_2015_Final_uploaded.pdf (0,7MB)
To view slides, click on images
Stroes_CHOICE_II_25_may_2015_Final_uploaded.pdf (0,7MB)
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: